Vaughan David Investments LLC Bristol Myers Squibb CO Transaction History
Vaughan David Investments LLC
- $4.35 Billion
- Q3 2024
A detailed history of Vaughan David Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vaughan David Investments LLC holds 7,777 shares of BMY stock, worth $437,222. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,777
Previous 59,578
86.95%
Holding current value
$437,222
Previous $2.47 Million
83.75%
% of portfolio
0.01%
Previous 0.06%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.6 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.92 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.22 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.38 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.43 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $120B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...